We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+1.04%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$18.4B
AUM Growth
+$120M
Cap. Flow
+$64.5M
Cap. Flow %
0.35%
Top 10 Hldgs %
43.98%
Holding
252
New
8
Increased
28
Reduced
110
Closed
4

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$285M
2
UNH icon
UnitedHealth
UNH
+$53.5M
3
GE icon
GE Aerospace
GE
+$36.4M
4
PEP icon
PepsiCo
PEP
+$12.5M
5
RL icon
Ralph Lauren
RL
+$10.1M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$39.4M
2
PM icon
Philip Morris
PM
+$20.6M
3
AAPL icon
Apple
AAPL
+$18.7M
4
KO icon
Coca-Cola
KO
+$17.7M
5
MO icon
Altria Group
MO
+$13.8M

Sector Composition

Rank Sector Weight
1 Consumer Staples 31.84%
2 Energy 18.16%
3 Financials 14.69%
4 Healthcare 10.53%
5 Technology 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MA icon
151
Mastercard
MA
$498B
$996K 0.01%
9,785
– –
MRSH
152
Marsh
MRSH
$94.3B
$976K 0.01%
14,500
– –
CADE
153
DELISTED
Cadence Bank
CADE
$970K 0.01%
41,800
– –
GD icon
154
General Dynamics
GD
$103B
$948K 0.01%
6,105
– –
C icon
155
Citigroup
C
$213B
$942K 0.01%
19,966
-392
-2% -$17.8K
MMP
156
DELISTED
Magellan Midstream Partners, L.P.
MMP
$897K ﹤0.01%
12,678
– –
BR icon
157
Broadridge
BR
$18.4B
$874K ﹤0.01%
12,900
– –
DD
158
DELISTED
Du Pont De Nemours E I
DD
$835K ﹤0.01%
12,473
– –
MJN
159
DELISTED
Mead Johnson Nutrition Company
MJN
$834K ﹤0.01%
10,560
-4,185
-28% -$357K
HWC icon
160
Hancock Whitney
HWC
$6.19B
$770K ﹤0.01%
23,743
– –
DNB
161
DELISTED
Dun & Bradstreet
DNB
$753K ﹤0.01%
5,512
-200
-4% -$26.8K
ECOL
162
DELISTED
US Ecology, Inc.
ECOL
$730K ﹤0.01%
16,280
– –
BAX icon
163
Baxter International
BAX
$12.8B
$724K ﹤0.01%
15,218
– –
AIG icon
164
American International
AIG
$42.5B
$723K ﹤0.01%
12,170
+4,008
+49% +$229K
CCEP icon
165
Coca-Cola Europacific Partners
CCEP
$49.1B
$718K ﹤0.01%
18,000
– –
BA icon
166
Boeing
BA
$169B
$701K ﹤0.01%
5,319
-95
-2% -$12.5K
CSX icon
167
CSX Corp
CSX
$94B
$671K ﹤0.01%
66,000
– –
NWS icon
168
News Corp Class B
NWS
$17.7B
$644K ﹤0.01%
45,335
-1,000
-2% -$13.6K
TWTR
169
DELISTED
Twitter, Inc.
TWTR
$634K ﹤0.01%
27,508
-1,000
-4% -$18.8K
VZ icon
170
Verizon
VZ
$197B
$618K ﹤0.01%
11,883
+1,745
+17% +$93.7K
BPL
171
DELISTED
Buckeye Partners, L.P.
BPL
$618K ﹤0.01%
8,635
– –
IDXX icon
172
Idexx Laboratories
IDXX
$44.9B
$612K ﹤0.01%
5,425
– –
PBR.A icon
173
Petrobras Class A
PBR.A
$106B
$609K ﹤0.01%
73,200
– –
FISV
174
Fiserv Inc
FISV
$29.7B
$572K ﹤0.01%
11,500
– –
FBIN icon
175
Fortune Brands Innovations
FBIN
$5.86B
$570K ﹤0.01%
11,485
– –
5 6
7
8 9

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Fayez Sarofim & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Fayez Sarofim & Co held 252 positions worth $18.4B, up 0.66% from $18.3B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Trading was light in Q3 2016: portfolio turnover was 4.8%. Fayez Sarofim & Co opened 8 new positions and exited 4, leaving the 252-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Staples at 32% of assets, down from 34% a quarter earlier, followed by Energy and Financials.

  • Fayez Sarofim & Co's largest Q3 2016 buy was UnitedHealth: 381,762 shares worth $53.3M.
  • Fayez Sarofim & Co added most to ExxonMobil in Q3 2016, an estimated $285M increase.
  • Fayez Sarofim & Co's biggest Q3 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $39.4M.
  • Fayez Sarofim & Co fully exited Rio Tinto in Q3 2016, selling an estimated $382K.
  • Fayez Sarofim & Co's ten largest holdings make up 44% of its $18.4B portfolio in Q3 2016.
  • Fayez Sarofim & Co opened 8 new positions and closed 4 in Q3 2016.
  • Fayez Sarofim & Co's portfolio value rose 0.66% quarter-over-quarter to $18.4B.

Based on Fayez Sarofim & Co's 13F filing for Q3 2016, filed 14 Nov 2016.